# IPRATROPIUM BROMIDE
> **ANDA219222** · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2025-01-14
## Drug
- **FDA Application Number:** ANDA219222
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IPRATROPIUM BROMIDE
- **Generic name:** IPRATROPIUM BROMIDE
- **Active ingredients:** IPRATROPIUM BROMIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** RUBICON RESEARCH
- **Manufacturer:** Advagen Pharma Ltd
- **First approval:** 2025-01-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219222)
---
*AI Analytics · CC0 1.0*